A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer

This publication has 52 references indexed in Scilit:

• [Arg6,D-Trp7,9,NmePhe8]-substance P (6–11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism
  British Journal of Cancer, 1999
• Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist G
  General Pharmacology: The Vascular System, 1997
• Characterization of the deamidase enzyme responsible for the metabolism of the anti-cancer peptide: H-Arg-d-Trp-NmePhe-d-Trp-Leu-Met-NH2
  Biochemical Pharmacology, 1995
• Pharmacokinetics, metabolism, tissue and tumour distribution of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]-substance P (6—11) in nude mice bearing the H69 small-cell lung cancer xenograft
  Annals of Oncology, 1995
• Substance P-related antagonists inhibit vasopressin and bombesin but not 5?-3-O-(thio) triphosphate-stimulated inositol phosphate production in swiss 3T3 cells
  Journal of Cellular Physiology, 1995
• Metabolism of the anticancer peptide: H-Arg-d-Trp-NmePhe-d-Trp-Leu-Met-NH2
  Peptides, 1995
• Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
  Proceedings of the National Academy of Sciences, 1991
• Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1991
• Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
  FEBS Letters, 1990
• [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.
  Proceedings of the National Academy of Sciences, 1988